Clinical Study

Risk Stratification by Cardiac Biomarkers following Emergency Gastrointestinal Surgery

Table 1

Demographic and clinical characteristics, according to survival.

Characteristics90-day survival
AliveDead
( š‘› = 3 9 )( š‘› = 9 )

Age (Mean (Ā±SD))68.8 (16.7)71.2 (13.9)
Gender, Male ( š‘› (%))24 (61.5)5 (55.6)
Comorbidities ( š‘› (%))
ā€ƒIschaemic heart disease 9 (23.7) 1 (11.1)
ā€ƒCongestive cardiac failure3 (7.9)0 (0)
ā€ƒCerebrovascular disease2 (5.3)0 (0)
ā€ƒType II diabetes mellitus7 (18.4)0 (0)
ā€ƒRenal impairment7 (18.4) 2 (22.2)
ā€ƒHypertension 13 (34.2) 5 (55.5)
ā€ƒHyperlipidaemia7 (18.4) 1 (11.1)
ā€ƒSmoker7 (18.4)0 (0)
Drug history ( š‘› (%))
ā€ƒAspirin3 (7.9)0 (0)
ā€ƒStatin 9 (23.7)1 (11.1)
ā€ƒBeta blocker 4 (10.5)3 (33.3)
ā€ƒACEI 9 (23.7)2 (22.2)
ā€ƒDiuretic 6 (15.8)2 (22.2)
ā€ƒCalcium channel blocker 6 (15.8)3 (33.3)
Risk scores (median (minā€“max))
ā€ƒASA score3 (1ā€“5) 4 (3ā€“4.5)
ā€ƒLee cardiac risk score2 (1ā€“4)2 (2ā€“4)